Chiome Bioscience Inc. (TYO:4583)
134.00
+1.00 (0.75%)
May 2, 2025, 3:30 PM JST
Chiome Bioscience Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 2,063 | 1,326 | 1,727 | 1,791 | 2,686 | Upgrade
|
Cash & Short-Term Investments | 2,063 | 1,326 | 1,727 | 1,791 | 2,686 | Upgrade
|
Cash Growth | 55.65% | -23.26% | -3.56% | -33.33% | 27.56% | Upgrade
|
Accounts Receivable | 51.06 | 83.19 | 115.22 | 25.46 | 56.78 | Upgrade
|
Other Receivables | 24.43 | 25.05 | 29.57 | 36.05 | 57.57 | Upgrade
|
Receivables | 75.49 | 108.24 | 144.79 | 61.51 | 114.35 | Upgrade
|
Inventory | 46.17 | 64.11 | 71.48 | 59.05 | 89.26 | Upgrade
|
Prepaid Expenses | 46.66 | 43.85 | 57.15 | 34.47 | 34.99 | Upgrade
|
Other Current Assets | 106.08 | 87.65 | 91.48 | 270.87 | 323.6 | Upgrade
|
Total Current Assets | 2,338 | 1,629 | 2,092 | 2,217 | 3,249 | Upgrade
|
Property, Plant & Equipment | - | 1.17 | 2.44 | 4.2 | 7.16 | Upgrade
|
Long-Term Investments | - | - | - | - | 150 | Upgrade
|
Other Long-Term Assets | 131.19 | 120.89 | 120.87 | 118.36 | 88.88 | Upgrade
|
Total Assets | 2,469 | 1,751 | 2,215 | 2,339 | 3,495 | Upgrade
|
Accounts Payable | 27.2 | 37.74 | 31.87 | 29.81 | 40.11 | Upgrade
|
Accrued Expenses | 29.56 | 32.32 | 32.91 | 44.46 | 36.69 | Upgrade
|
Short-Term Debt | 281.5 | 291 | 184 | 183 | 180 | Upgrade
|
Current Income Taxes Payable | 2.53 | 23.95 | 23.94 | 16.75 | 3.24 | Upgrade
|
Other Current Liabilities | 152.65 | 154.03 | 97.74 | 118.53 | 82.68 | Upgrade
|
Total Current Liabilities | 493.43 | 539.04 | 370.46 | 392.54 | 342.71 | Upgrade
|
Other Long-Term Liabilities | 55.12 | 54.69 | 54.27 | 53.85 | 41.87 | Upgrade
|
Total Liabilities | 548.55 | 593.73 | 424.72 | 446.39 | 384.59 | Upgrade
|
Common Stock | 995.53 | 2,388 | 2,097 | 1,516 | 1,388 | Upgrade
|
Retained Earnings | 915.02 | -1,248 | -319.53 | 342.02 | 1,694 | Upgrade
|
Treasury Stock | -0.29 | -0.29 | -0.29 | -0.29 | -0.29 | Upgrade
|
Comprehensive Income & Other | 10.05 | 17.74 | 13.55 | 35.4 | 28.92 | Upgrade
|
Total Common Equity | 1,920 | 1,158 | 1,791 | 1,893 | 3,110 | Upgrade
|
Shareholders' Equity | 1,920 | 1,158 | 1,791 | 1,893 | 3,110 | Upgrade
|
Total Liabilities & Equity | 2,469 | 1,751 | 2,215 | 2,339 | 3,495 | Upgrade
|
Total Debt | 281.5 | 291 | 184 | 183 | 180 | Upgrade
|
Net Cash (Debt) | 1,782 | 1,035 | 1,543 | 1,608 | 2,506 | Upgrade
|
Net Cash Growth | 72.23% | -32.96% | -4.03% | -35.84% | 19.01% | Upgrade
|
Net Cash Per Share | 30.61 | 20.88 | 35.09 | 39.92 | 69.85 | Upgrade
|
Filing Date Shares Outstanding | 66.96 | 52.63 | 48.42 | 40.78 | 39.51 | Upgrade
|
Total Common Shares Outstanding | 66.96 | 52.63 | 48.42 | 40.78 | 39.51 | Upgrade
|
Working Capital | 1,844 | 1,090 | 1,722 | 1,824 | 2,906 | Upgrade
|
Book Value Per Share | 28.68 | 22.00 | 36.98 | 46.42 | 78.72 | Upgrade
|
Tangible Book Value | 1,920 | 1,158 | 1,791 | 1,893 | 3,110 | Upgrade
|
Tangible Book Value Per Share | 28.68 | 22.00 | 36.98 | 46.42 | 78.72 | Upgrade
|
Machinery | 312.86 | 318.96 | 351.63 | 387.39 | 391.26 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.